The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Artemis 2 will be the first mission to carry humans to the moon's vicinity since 1972. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Artemis 2 ...